Gil Hakim

2017

In 2017, Gil Hakim earned a total compensation of $1.3M as Former President at UroGen Pharma Ltd., a 219% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$114,242
Option Awards$778,733
Salary$390,406
Other$60,164
Total$1,343,545

Hakim received $778.7K in option awards, accounting for 58% of the total pay in 2017.

Hakim also received $114.2K in non-equity incentive plan, $390.4K in salary and $60.2K in other compensation.

Rankings

In 2017, Gil Hakim's compensation ranked 7,548th out of 14,666 executives tracked by ExecPay. In other words, Hakim earned more than 48.5% of executives.

ClassificationRankingPercentile
All
7,548
out of 14,666
49th
Division
Manufacturing
2,824
out of 5,768
51st
Major group
Chemicals And Allied Products
915
out of 2,074
56th
Industry group
Drugs
713
out of 1,730
59th
Industry
Pharmaceutical Preparations
555
out of 1,329
58th
Source: SEC filing on April 26, 2019.

Hakim's colleagues

We found three more compensation records of executives who worked with Gil Hakim at UroGen Pharma Ltd. in 2017.

2017

Ron Bentsur

UroGen Pharma Ltd.

Chief Executive Officer

2017

Gary Titus

UroGen Pharma Ltd.

Chief Financial Officer

2017

Mark Schoenberg

UroGen Pharma Ltd.

Chief Medical Officer

News

In-depth

You may also like